Evaluation of the gastric cancer treatment guidelines of the Japanese gastric cancer association

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 4, 2010, Pages 582-586

  Sano, Takeshi ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Adjuvant chemotherapy; Gastric cancer; Lymphadenectomy; Treatment guidelines

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER SURGERY; COMPARATIVE STUDY; ENDOSCOPIC MUCOSAL RESECTION; GASTRECTOMY; GOLD STANDARD; HEALTH CARE PERSONNEL; HUMAN; JAPAN; JAPANESE; LARGE SCALE PRODUCTION; LYMPHADENECTOMY; MEDICAL SOCIETY; PRACTICE GUIDELINE; STANDARD; STOMACH CANCER;

EID: 79960747999     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. (http://www.jgca.jp/)
2. Sakuramoto S, Sasako M, Yamaguchi T, et al: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357: 1810-1820, 2007.
3. Sasako M, Sano T, Yamamoto S, et al: D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 359: 453-462, 2008.
4. Koizumi W, Narahara H, Hara T, et al: S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9: 215-221, 2008.
5. Boku N, Yamamoto S, Fukuda H, et al: Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol 10: 1063-1069, 2009.
6. Ichikura T, Ogawa T, Majima T, et al: Evaluation of the gastric cancer treatment guidelines for popular use by the Japanese Gastric Cancer Association. Gastric Cancer 7: 41-45, 2004. (Pubitemid 38470694)